CH469002A - Verfahren zur Herstellung neuer Indolderivate - Google Patents

Verfahren zur Herstellung neuer Indolderivate

Info

Publication number
CH469002A
CH469002A CH898666A CH898666A CH469002A CH 469002 A CH469002 A CH 469002A CH 898666 A CH898666 A CH 898666A CH 898666 A CH898666 A CH 898666A CH 469002 A CH469002 A CH 469002A
Authority
CH
Switzerland
Prior art keywords
production
indole derivatives
new indole
new
derivatives
Prior art date
Application number
CH898666A
Other languages
English (en)
Inventor
Franz Dr Troxler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH898666A priority Critical patent/CH469002A/de
Priority to CS155767A priority patent/CS156407B2/cs
Priority to FI670617A priority patent/FI47366C/fi
Priority to ES337458A priority patent/ES337458A1/es
Priority to SE2931/67A priority patent/SE308110B/xx
Priority to AT206067A priority patent/AT266822B/de
Priority to DK112967AA priority patent/DK124612B/da
Publication of CH469002A publication Critical patent/CH469002A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
CH898666A 1966-06-21 1966-06-21 Verfahren zur Herstellung neuer Indolderivate CH469002A (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CH898666A CH469002A (de) 1966-06-21 1966-06-21 Verfahren zur Herstellung neuer Indolderivate
CS155767A CS156407B2 (de) 1966-06-21 1967-03-02
FI670617A FI47366C (fi) 1966-06-21 1967-03-02 Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
ES337458A ES337458A1 (es) 1966-06-21 1967-03-02 Procedimiento para la produccion de derivados indolicos.
SE2931/67A SE308110B (de) 1966-06-21 1967-03-03
AT206067A AT266822B (de) 1966-06-21 1967-03-03 Verfahren zur Herstellung neuer Indolderivate und ihrer Salze
DK112967AA DK124612B (da) 1966-06-21 1967-03-03 Analogifremgangsmåde til fremstilling af indolderivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH898666A CH469002A (de) 1966-06-21 1966-06-21 Verfahren zur Herstellung neuer Indolderivate

Publications (1)

Publication Number Publication Date
CH469002A true CH469002A (de) 1969-02-28

Family

ID=4347068

Family Applications (1)

Application Number Title Priority Date Filing Date
CH898666A CH469002A (de) 1966-06-21 1966-06-21 Verfahren zur Herstellung neuer Indolderivate

Country Status (7)

Country Link
AT (1) AT266822B (de)
CH (1) CH469002A (de)
CS (1) CS156407B2 (de)
DK (1) DK124612B (de)
ES (1) ES337458A1 (de)
FI (1) FI47366C (de)
SE (1) SE308110B (de)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000152A1 (en) * 1978-07-03 1980-02-07 Sandoz Ag 3-aminopropoxy-aryl derivates,preparation and use thereof
EP0013878A1 (de) * 1979-01-18 1980-08-06 Sandoz Ag 3-Aminopropoxyaryl-Derivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
WO2007024945A1 (en) 2005-08-25 2007-03-01 Novartis Ag Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (de) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazinderivate und ihre verwendung als lxr-modulatoren
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US10251959B2 (en) 2007-03-12 2019-04-09 Nektar Therapeutics Oligomer-beta blocker conjugates
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000152A1 (en) * 1978-07-03 1980-02-07 Sandoz Ag 3-aminopropoxy-aryl derivates,preparation and use thereof
EP0013878A1 (de) * 1979-01-18 1980-08-06 Sandoz Ag 3-Aminopropoxyaryl-Derivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EP2256118A1 (de) 2005-08-25 2010-12-01 Novartis AG Kondensierte Imidazol-Derivative zur Inhibierung der Aromatase
WO2007024945A1 (en) 2005-08-25 2007-03-01 Novartis Ag Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
EP2270011A1 (de) 2005-08-25 2011-01-05 Novartis AG Kondensierte Imidazol-Derivative zur Inhibierung der Aromatase
EP2392567A1 (de) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazinderivate und ihre verwendung als lxr-modulatoren
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US10251959B2 (en) 2007-03-12 2019-04-09 Nektar Therapeutics Oligomer-beta blocker conjugates
US10881738B2 (en) 2007-03-12 2021-01-05 Nektar Therapeutics Oligomer-beta blocker conjugates
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
DK124612B (da) 1972-11-06
AT266822B (de) 1968-12-10
SE308110B (de) 1969-02-03
CS156407B2 (de) 1974-07-24
FI47366C (fi) 1973-11-12
FI47366B (de) 1973-07-31
ES337458A1 (es) 1968-03-01

Similar Documents

Publication Publication Date Title
CH538494A (de) Verfahren zur Herstellung neuer Homopyrimidazol-Derivate
CH513111A (de) Verfahren zur Herstellung neuer Benz-epinderivate
AT263765B (de) Verfahren zur Herstellung neuer Indolderivate
CH532040A (de) Verfahren zur Herstellung neuer Indolderivate
CH469002A (de) Verfahren zur Herstellung neuer Indolderivate
CH526579A (de) Verfahren zur Herstellung neuer Benziodoxanderivate
CH504426A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT279636B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
CH476726A (de) Verfahren zur Herstellung von Indolderivaten
CH476723A (de) Verfahren zur Herstellung neuer Isoindol-Derivate
CH475981A (de) Verfahren zur Herstellung neuer Indol-Derivate
CH475252A (de) Verfahren zur Herstellung neuer Lysergsäure-Derivate
CH500972A (de) Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate
AT256097B (de) Verfahren zur Herstellung neuer Indolderivate
CH535762A (de) Verfahren zur Herstellung neuer Indolderivate
CH473807A (de) Verfahren zur Herstellung neuer 4-Hydroxy-chinoline
AT249667B (de) Verfahren zur Herstellung neuer Indolderivate
CH467779A (de) Verfahren zur Herstellung neuer Indol-Derivate
AT276379B (de) Verfahren zur Herstellung neuer Indolderivate
AT277993B (de) Verfahren zur Herstellung neuer Indolderivate
AT310962B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate
CH471140A (de) Verfahren zur Herstellung neuer Indolderivate
AT266106B (de) Verfahren zur Herstellung neuer Nitrofuranderivate
CH484902A (de) Verfahren zur Herstellung neuer Indol-Derivate
AT300806B (de) Verfahren zur Herstellung neuer Piperodin-Derivate